title: Editorial comment May cyclooxygenase-2 (COX-2), p21 and p27 expression affect prognosis and therapeutic strategy of patients with malignant pleural mesothelioma?
authors.forename: Isabelle
authors.initials: I
authors.lastname: Opitz
mesh_terms: D014408:Biomarkers, Tumor / Q000378:metabolism*; D003131:Combined Modality Therapy; D050759:Cyclin-Dependent Kinase Inhibitor p21 / Q000378:metabolism; D051546:Cyclooxygenase 2 / Q000378:metabolism; D006801:Humans; D008654:Mesothelioma / Q000175:diagnosis* / Q000628:therapy; D009363:Neoplasm Proteins / Q000378:metabolism; D010997:Pleural Neoplasms / Q000175:diagnosis* / Q000628:therapy; D011379:Prognosis
chemical_list: D014408:Biomarkers, Tumor; C493956:CDKN1A protein, human; D050759:Cyclin-Dependent Kinase Inhibitor p21; D009363:Neoplasm Proteins; D051546:Cyclooxygenase 2